TrademarkDir
ATROPINE SULFATE OPHTHALMIC SOLUTION 0.01% OMNI BY OSRX
LIVE

Serial Number

88423638

Owner

OSRX, Inc.

Attorney

Brendan J. Hughes

First Use Date

May 1, 2019

Filing Date

May 9, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ATROPINE SULFATE OPHTHALMIC SOLUTION 0.01% OMNI BY OSRX Trademark

Serial Number: 88423638 • Registration: 6342254

ATROPINE SULFATE OPHTHALMIC SOLUTION 0.01% OMNI BY OSRX is a trademark filed by OSRX, Inc. on May 9, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

OSRX, Inc.

1120 Kensington Ave., Suite E
Missoula, MT 59801

Entity Type: 03

Trademark Details

Filing Date

May 9, 2019

Registration Date

May 4, 2021

First Use Anywhere

May 1, 2019

First Use in Commerce

May 1, 2019

Published for Opposition

March 3, 2020

Goods & Services

Ophthalmic preparations containing atropine sulfate

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 4, 2026 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 21, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 21, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 21, 2025 REAP
WITHDRAWAL OF ATTORNEY GRANTED
Mar 10, 2025 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Mar 10, 2025 WOAR
REGISTERED-PRINCIPAL REGISTER
May 4, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 30, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 29, 2021 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 26, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 26, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 6, 2020 GNRN
NON-FINAL ACTION E-MAILED
Oct 6, 2020 GNRT
SU - NON-FINAL ACTION - WRITTEN
Oct 6, 2020 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Oct 2, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 2, 2020 AITU
USE AMENDMENT FILED
Sep 17, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 17, 2020 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 28, 2020 NOAM
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 2, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 2, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 2, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 2, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 2, 2020 COAR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 12, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 29, 2020 CNSA
ASSIGNED TO LIE
Jan 29, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 24, 2020 TROA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 23, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 22, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 22, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 25, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jul 25, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jul 25, 2019 CNRT
ASSIGNED TO EXAMINER
Jul 24, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 25, 2019 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 24, 2019 NWOS
NEW APPLICATION ENTERED
May 13, 2019 NWAP

Related Trademarks

More from this Owner

WE ARE WITH YOU EVERY DROP OF THE WAY

WE ARE WITH YOU EVERY DROP OF THE WAY

WE ARE WITH YOU EVERY DROP OF THE WAY

WE ARE WITH YOU EVERY DROP OF THE WAY

A NEW VIEW OF MEDICINE

A NEW VIEW OF MEDICINE

A NEW VIEW OF MEDICINE

A NEW VIEW OF MEDICINE

A NEW VIEW OF MEDICINE

A NEW VIEW OF MEDICINE

DEXAMETHASONE PO4 / MOXIFLOXACIN HCL 0.1% / 0.5% (SINGLE USE) OMNI BY OSRX logo

DEXAMETHASONE PO4 / MOXIFLOXACIN HCL 0.1% / 0.5% (SINGLE USE) OMNI BY OSRX